rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ORGO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Organogenesis Holdings Inc (ORGO) Q3 2026 Earnings Call Highlights: Market Bottom, Cost Cuts, ...

      Organogenesis Holdings Inc (ORGO) posted 6% sequential revenue growth and sharp expense reductions while navigating a 70% revenue decline and an extended Amnuvix PDUFA timeline.

      Nov 7Yahoo FinanceORGO
      Organogenesis Holdings Inc. Q3 2026 Earnings Call Summary
      Nov 6Yahoo FinanceORGO
      Organogenesis: 3 Key Takeaways for Long-Term Investors
      Nov 6Yahoo FinanceORGO
      Organogenesis (ORGO) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 6The Globe and MailORGO
      Organogenesis Q3 Earnings Call Highlights
      Nov 6Yahoo FinanceORGO
      Organogenesis Holdings Q3 2026 Earnings Call Transcript
      Nov 5BenzingaORGO
      Organogenesis Holdings earnings missed by $0.07, revenue fell short of estimates
      Nov 5Investing.comORGO
      Organogenesis: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceORGO
      Organogenesis announces publication of diabetic foot ulcer trial
      Oct 12Investing.comORGO

      This is the newest page. Registered accounts read further back.